![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » HOLLISTERSTIER SEES CONTRACT IN PRISM
HOLLISTERSTIER SEES CONTRACT IN PRISM
April 14, 2006
HollisterStier has signed a deal to develop a process for compounding and fill/finishing PM101, Prism's acute care cardiovascular drug. Under the deal, HollisterStier will produce PM101 registration material for clinical trials and is supporting Prism'filing of a new drug application (NDA).
Big News (http://feeds.bignewsnetwork.com/redir.php?jid=61af44539a63ab84&cat=6dcd932030878143)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct